| ANTGX | OAZIX | ANTGX / OAZIX | |
| Total Expense Ratio | 0.02 | 0.75 | 3% |
| Annual Report Gross Expense Ratio | 0.82 | 0.75 | 109% |
| Fund Existence | 7 years | 5 years | - |
| Gain YTD | 34.410 | 23.536 | 146% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 546M | 14.4B | 4% |
| Annual Yield % from dividends | 3.09 | 2.23 | 139% |
| Returns for 1 year | 19.99 | 24.29 | 82% |
| Returns for 3 years | 42.08 | 38.01 | 111% |
| Returns for 5 years | 42.93 | N/A | - |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BXMX | 14.12 | 0.08 | +0.57% |
| NUVEEN S&P BUY-WRITE Income FUND | |||
| INFO | 23.82 | 0.06 | +0.23% |
| Harbor PanAgora Dynamic Lg Cp Cor ETF | |||
| IQHI | 26.12 | N/A | N/A |
| NYLI MacKay High Income ETF | |||
| CAPE | 31.47 | -0.20 | -0.62% |
| DoubleLine Shiller CAPE US Equities ETF | |||
| IBRN | 29.58 | -0.24 | -0.82% |
| iShares Neuroscience and Healthcare ETF | |||